News: Avila In The News

Below, you will find links to articles that describe our company and that illustrate how our science works and that describe our product pipeline.

12.12.11
Xconomy
"Avila Shows Progress in Covalent Cancer Drugs at Prominent ASH Confab"

09.05.11
Chemical & Engineering News
"Covalent Drugs Form Long-Lived Ties"

12.21.10
BioWorld Today
"Avila, Sanofi-Aventis Shake Hands on $800M Alliance"

12.01.10
Chemical and Engineering News
"Sticking Fast To Foil Hepatitis C"

11.01.10
Start-Up
"Tying up viral resistance with covalent bonds"

09.15.10
Fierce Biotech
" Avila Named as One of the "Fierce 15" Biotech Companies of 2010"

05.26.10
BioWorld Today
"Clovis Partners with Avila in $209M NSCLC Deal"

05.25.10
Xconomy
"Avila Therapeutics Strikes $209M Lung Cancer Deal with Clovis Oncology"

05.15.10
Genetic Engineering News
"R&D in the Protein Kinase Field Blossoms"

02.26.10
Xconomy
"Avila Aims to Trump Vertex With Drug that Hits Hepatitis C Virus and Won't Let Go"

02.12.10
Pharmawire
"Avila Therapeutics to Advance Lead Covalent Drug Programs to Clinic this Year"

01.28.10
BIO-IT World
"Avila Therapeutics Targets the Covalent Proteome"

09.25.09
EP Vantage
"Avila covalent drugs looking highly attractive"

09.01.09
Drug Discovery News
"Novartis sponsors Avila Therapeutics' covalent drug candidate"

07.28.09
BioWorld Today
"Avila Raises $30M, Pulls Down $200M deal with Novartis Fund"

04.27.09
Xconomy
"Avila Therapeutics May Have Found Achilles Heel of Hepatitis C Virus"

12.08.08
Xconomy
"Avila Comes Out of Stealth to Talk Bonds, Covalent Bonds"